Currently, Park Ha Biological Technology Co Ltd’s (PHH) stock is trading at $0.96, marking a fall of -7.80% from last night’s close. At this price, the stock is -97.69% below its 52-week high of $41.49 and -6.90% above its 52-week low of $1.03. Based on the past 30-day period, the stock price is -97.84% below the high and +2.05% above the low.
As well, it is important to consider PHH stock ratios such as price-to-sales, which is currently 10.62.Likewise, its price to free cash flow for the last twelve months stands at 29.06. PHH’s price to book ratio for the most recent quarter was 15.92, resulting in an 45.97 price to cash per share for the period.
How does Park Ha Biological Technology Co Ltd (PHH) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Park Ha Biological Technology Co Ltd (PHH): Earnings History
If we examine Park Ha Biological Technology Co Ltd’s recent earnings history, in the last quarter ended on Next Year (1970), it posted adjusted earnings per share of $0, slashing the consensus of $0. In other words, it topped the consensus by $0, resulting in a 0 surprise. In the 3 months period before the previous quarter which was closed on Next Year (1970), the stock recorded adjusted earnings per share of $0 in contrast with the Outlook of $0. That was a difference of $0 and a surprise of 0.
Park Ha Biological Technology Co Ltd (NASDAQ: PHH) Ownership Details
I will give a breakdown of the key shareholders in Park Ha Biological Technology Co Ltd (PHH). Recent figures show that the company’s insiders hold 81.71% of shares. A total of 4 institutional investors hold shares in the company, making 0.19% of its stock and 1.05% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Geode Capital Management, LLC holding total of 16.79 shares that make 0.00% of the company’s total number of shares and are currently priced at 15945.0.
The securities firm Citadel Advisors Llc holds 16.61 shares of PHH, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.00% , and the holding percentage of shares is valued at 15775.0.
An overview of Park Ha Biological Technology Co Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Park Ha Biological Technology Co Ltd (PHH) traded 3,343,087 shares per day, with a moving average of $23.7179 and price change of -17.9620. With the moving average of $18.4832 and a price change of -13.4220, about 1,538,087 shares changed hands on average over the past 50 days. Finally, PHH’s 100-day average volume is 956,272 shares, alongside a moving average of $14.4624 and a price change of -4.7020.
